Lucid Diagnostics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Lucid Diagnostics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- LUCD
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001799011
Board of directors
-
Debra White · DirectorSince 2023
-
Dennis Matheis · DirectorSince 2024
-
Jacque J. Sokolov · DirectorSince 2023
-
James L. Cox · DirectorSince 2023
-
Lishan Aklog · Director · Chief Executive OfficerSince 2024
-
Ronald M. Sparks · DirectorSince 2023
-
Stanley Lapidus · DirectorSince 2023
Chief executives
Lishan Aklog
· Chief Executive Officer
Dates unknown
Board connections
4 of this board's directors also sit on 3 other boards.
- via Debra White, James L. Cox and Ronald M. Sparks
- via James L. Cox
- via Dennis Matheis
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 7, 2024 | Gordon Michael Adam Officer (General Counsel and Secretary) | Grant or award | +400,000 | — | — |
| May 7, 2024 | O'Neil Shaun Officer (President and COO) | Grant or award | +400,000 | — | — |
| May 7, 2024 | Dennis M. Mcgrath Officer (Chief Financial Officer) | Grant or award | +400,000 | — | — |
| May 7, 2024 | Lishan Aklog Director, Officer (Chief Executive Officer) | Grant or award | +400,000 | — | — |
| Feb 15, 2024 | PAVmed Inc. 10% owner | Other | −3,331,747 | — | — |
| Jan 26, 2024 | PAVmed Inc. 10% owner | Other | +3,331,771 | $1.40 | $4,664,479 |
| Sep 26, 2023 | Stanley Lapidus Director | Open-market sale | −10,000 | $1.47 | $14,700 |
| Sep 26, 2023 | Stanley Lapidus Director | Open-market sale | −10,000 | $1.43 | $14,300 |
| Sep 26, 2023 | Stanley Lapidus Director | Open-market sale | −9,747 | $1.45 | $14,133 |
| Sep 25, 2023 | Stanley Lapidus Director | Open-market sale | −200 | $1.43 | $286 |
| Sep 21, 2023 | Stanley Lapidus Director | Open-market sale | −100 | $1.44 | $144 |
| Sep 20, 2023 | Stanley Lapidus Director | Open-market sale | −3,405 | $1.45 | $4,937 |
| Sep 20, 2023 | Stanley Lapidus Director | Open-market sale | −412 | $1.44 | $593 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.